Healios Kk (4593.T) traded up 3.33 % during a 24 hours period ending at 10:46 AM Central Europe on Wednesday 28th. One Healios Kk stock can currently be bought for about JPY 285 on popular exchanges. Current supply of Healios Kk stocks is 131.2 mn. Healios Kk has a current market capitalization of JPY 36.6 bn and approximately JPY 230.9 mn worth of Healios Kk was traded on exchanges in the last 24 hours. Since last month end, Healios Kk has traded -2.45 % down. Simple moving average of last 200 days is at JPY 316.52. The highest price of past 52 weeks was recorded at JPY 499 on 11/28/2025. 52 weeks low was at JPY 208 on 07/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Yamatane (9305.T) traded down -0.83 % and now trades at JPY 1,991. Current market capitalisation for Yamatane is JPY 43.3 bn. Yamatane has a current price to earnings ratio of 8.61.

  • Sec Carbon (5304.T) traded up 1.24 % and now trades at JPY 2,188. Current market capitalisation for Sec Carbon is JPY 43.3 bn. Sec Carbon has a current price to earnings ratio of 92.69.

  • Toyo Securities (8614.T) traded flat 0 % and now trades at JPY 637. Toyo Securities has a market capitalisation of JPY 43.5 bn. Toyo Securities has a current price to earnings ratio of 8.52.

  • Alpha (4719.T) traded down -0.16 % and now trades at JPY 3,060. Alpha has a market capitalisation of JPY 43.8 bn. Current price/earnings ratio for Alpha is 11.61.

  • Tenpos (2751.T) traded down -0.7 % and now trades at JPY 3,520. Current market capitalisation for Tenpos is JPY 43.8 bn. Current price/earnings ratio for Tenpos is 25.27.

About Healios Kk

Healios K.K., a company headquartered in Tokyo, Japan, specializes in cell therapy and regenerative medicine research and development, as well as their manufacturing. The company has license agreements with other biotechnology companies like Athersys for the development of regenerative medicine products. Healios K.K. was previously known as Retina Institute Japan, K.K., but changed its name to Healios K.K. in September 2013. The IPO of the company took place on June 16, 2015, at the Tokyo Stock Exchange. The company’s website is www.healios.co.jp , and they are involved in the health care sector, with a focus on biotechnology.